In addition, HCQ treatment significantly attenuated splenomegaly observed in PIL mice, accompanied by increased expression of MerTK and Gas6 in the spleen, suggesting that HCQ may promote restoration of efficient efferocytosis systemically. The gene discussed is MERTK; the disease is Splenomegaly.